Table 2.
Guidelines | Basic resuscitation | VTE, DVT prophylaxis | Infection and IPC | Advanced resuscitation | Avoid* | Other | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fluid resuscitation | Supplemental oxygen | Nutrition | Symptom control, including NSAIDs | IPC | Empirical antibiotics | Antiviral therapy | Intubation and ventilation | RRT | Vasopressors and inotropes | Steroids | NIV | |||||
WHO9 | X | X | X | X | X | X | X | X | X | |||||||
Brazil10 | X | X | X | X | X | X | X | X | ||||||||
China5 | X | X | X | X | X | X | X | X | Traditional Chinese medicine | |||||||
France11 | X | X | X | X | X | X | ||||||||||
Germany12 | X | X | X | X | X | X | ||||||||||
Netherlands26† | X | |||||||||||||||
India14 | X | X | X | X | X | X | X | X | X | Early prone positioning | ||||||
Indonesia13 | X | X | X | X | X | X | X | X | ||||||||
Italy15 | X | X | X | X | ||||||||||||
Japan16 | X | X | ||||||||||||||
Malaysia17 | X | X | X | |||||||||||||
Russia18 | X | X | X | X | X | X | X | |||||||||
Saudi Arabia19‡ | X | |||||||||||||||
South Korea20† | X | X | ||||||||||||||
Spain21 | X | X | X | X | X | X | X | X | X | X | Early prone positioning | |||||
Taiwan22 | X | X | X | X | X | X | X | X | ||||||||
Turkey23 | X | X | X | X | X | |||||||||||
US CDC24‡ | X | X | X | X | X | X | X |
CDC=Centers for Disease Control and Prevention; DVT=deep venous thrombosis; IPC=infection prevention and control; NIV=non-invasive ventilation; NSAID=non-steroidal anti-inflammatory drug; RRT=renal replacement therapy; VTE=venous thromboembolism; WHO=World Health Organization.
Guidelines specifically recommend against particular intervention.
Provides no original supportive care guidelines; refers user directly to WHO clinical guidelines and Surviving Sepsis.
Focus of guidelines was on antiviral drugs.